Dr. Lal PathLabs Limited
NSE:LALPATHLAB.NS
Sector
Location
Market Cap
USD 3.06 B
Share Price
USD 36.37
Avg Daily Volume
144,470
Change (1 day)
-1.01%
Change (1 year)
-4.13%
Change (YTD)
3.77%
Dr. Lal PathLabs Limited Operating Cash Flow for the year ending March 31, 2025: USD 66.56 M
Dr. Lal PathLabs Limited Operating Cash Flow is USD 66.56 M for the year ending March 31, 2025, a 3.71% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Dr. Lal PathLabs Limited Operating Cash Flow for the year ending March 31, 2024 was USD 64.18 M, a 15.68% change year over year.
-
Dr. Lal PathLabs Limited Operating Cash Flow for the year ending March 31, 2023 was USD 55.48 M, a -5.69% change year over year.
-
Dr. Lal PathLabs Limited Operating Cash Flow for the year ending March 31, 2022 was USD 58.83 M, a 8.19% change year over year.
-
Dr. Lal PathLabs Limited Operating Cash Flow for the year ending March 31, 2021 was USD 54.38 M, a 44.34% change year over year.
StockViz
Competitors
Labcorp Holdings Inc.
USD 265.85
LH
+5.89
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
AddLife AB (publ)
USD 17.10
ALIF-B.ST
-0.17
-1.00%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.07
-1.63%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Chugai Pharmaceutical Co., Ltd.
USD 41.22
4519.T
-9.07
-18.03%
Regeneron Pharmaceuticals, Inc.
USD 563.00
REGN
+3.20
0.57%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Labcorp Holdings Inc.
USD 265.85
LH
+5.89
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
AddLife AB (publ)
USD 17.10
ALIF-B.ST
-0.17
-1.00%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.07
-1.63%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Chugai Pharmaceutical Co., Ltd.
USD 41.22
4519.T
-9.07
-18.03%
Regeneron Pharmaceuticals, Inc.
USD 563.00
REGN
+3.20
0.57%